EWAN KIRK

Kirk was born in February 1961 and trained as a scientist long before he touched a trading floor. He earned a physics and astronomy degree at Glasgow, studied advanced maths at Cambridge, and picked up a PhD in general relativity at Southampton, which is roughly the physics of black holes and gravity.

In 1992 he joined Goldman Sachs, moved from commodities to currencies, made managing director in 1998 and partner in 2000. At Goldman he ran the European group testing systematic strategies, leading a team of around 120 scientists and mathematicians.

In 2006 he left that partnership to co-found Cantab Capital Partners in Cambridge with Erich Schlaikjer. Cantab grew from two people and 30 million pounds to roughly 60 people and 4.5 billion pounds by 2016, when it was acquired by GAM Investments and folded into GAM Systematic.

Kirk stayed on as president of that unit until March 2021.

Cantab Capital Partners, GAM Systematic, Turner Kirk Trust

Kirk runs money the way a scientist runs an experiment. Cantab used computer models to trade futures and other liquid markets systematically, meaning the rules are set in advance and the machine executes them without emotion.

His core insight is contrarian for the industry. He argued the models are not the secret sauce.

The real edge is the research architecture, the unglamorous software plumbing that lets you test ideas cleanly and turn them into live trades. He was deeply skeptical of the marketing hype around artificial intelligence in finance, warning investors to focus on real results rather than buzzwords.

He believed markets are messy and goal-shifting in a way that trips up techniques borrowed from cleaner fields like game-playing AI.

The win was Cantab itself, a firm he built from almost nothing into a 4.5 billion pound machine in a decade. Starting in 2006 with a partner and 30 million pounds, he scaled it to roughly 60 people and billions under management, then sold it to GAM in 2016.

That is a rare full-cycle success in a business where most startup funds quietly die. He proved that a science-first Cambridge outfit could compete with the big American systematic shops that had spent billions on technology.

Timing and partners both bit him. Cantab sold to GAM in 2016, right as many systematic and trend-following funds hit a brutal stretch of weak performance in stubbornly calm, hard-to-trade markets.

Tying Cantab's brand to GAM also linked it to a firm that soon after was rocked by an unrelated bond-fund scandal that hammered GAM's reputation and assets. Kirk exited as president of GAM Systematic in 2021.

The lesson is one every fund founder learns eventually. Selling at scale can mean handing your life's work to a buyer whose future you do not control.

Kirk believes discipline is everything, and that you cannot be half-systematic any more than you can be half-pregnant. Either a machine follows the rules or a human overrides them, and the moment humans override, the edge leaks away.

He credits scientific rigor for Cantab's rise, treating the firm more like a research organization than a trading shop. He is allergic to hype and once told investors to buy the steak, not the sizzle, when it came to fashionable technology claims.

In his view, the boring infrastructure behind a strategy matters far more than the clever idea on top.

Kirk is married to Dr. Patricia Turner, a fellow scientist, and the two run the Turner Kirk Trust together.

Beyond their shared philanthropy, they keep their personal life largely out of the press.

Kirk is a career scientist. He earned a BSc in natural philosophy and astronomy at the University of Glasgow, studied Part III of the Mathematical Tripos at Cambridge, and completed a PhD in general relativity at Southampton.

That deep training in physics and hard maths is exactly what he later pointed at financial markets, and it shaped his belief that rigor beats hype.